Investigators
Publication Date
2021-10-18
Volume
181
Issue
12
Page Numbers
1673–1675
Full Citation
Shahzad M, Naci H, Wagner AK. Estimated Medicare Spending on Cancer Drug Indications With a Confirmed Lack of Clinical Benefit After US Food and Drug Administration Accelerated Approval. JAMA Intern Med. 2021 Dec 1;181(12):1673-1675. doi: 10.1001/jamainternmed.2021.5989. PMID: 34661616; PMCID: PMC8524351.
Pubmed ID
34661616
Full Title
Estimated Medicare Spending on Cancer Drug Indications With a Confirmed Lack of Clinical Benefit After US Food and Drug Administration Accelerated Approval